Diabetes treatment is constantly progressing, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://vinnydxuw571598.wiki-jp.com/2002084/novel_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment